Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000756532 | SCV000884367 | uncertain significance | not provided | 2018-06-22 | criteria provided, single submitter | clinical testing | The PKD1 c.9199C>T; p.Pro3067Ser variant, to our knowledge, is not reported in the medical literature or gene specific databases. This variant is absent from general population databases (1000 Genomes Project, Exome Variant Server, and Genome Aggregation Database), indicating it is not a common polymorphism. The proline at codon 3067 is highly conserved, but computational analyses (SIFT: tolerated, PolyPhen-2: probably damaging) predict conflicting effects of this variant on protein structure/function. Due to limited information, the clinical significance of the p.Pro3067Ser variant is uncertain at this time. |
Gene |
RCV000756532 | SCV002013836 | uncertain significance | not provided | 2024-06-18 | criteria provided, single submitter | clinical testing | Not observed at significant frequency in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Fulgent Genetics, |
RCV002493377 | SCV002793594 | uncertain significance | Polycystic kidney disease, adult type | 2021-12-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003396318 | SCV004104740 | uncertain significance | PKD1-related disorder | 2023-02-20 | criteria provided, single submitter | clinical testing | The PKD1 c.9199C>T variant is predicted to result in the amino acid substitution p.Pro3067Ser. To our knowledge, this variant has not been reported in the literature or in a large population database (http://gnomad.broadinstitute.org), indicating this variant is rare. This variant falls within a highly paralogous region. Allele frequency data should be interpreted with caution. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. |
Ambry Genetics | RCV004958074 | SCV005475102 | uncertain significance | Inborn genetic diseases | 2024-08-12 | criteria provided, single submitter | clinical testing | The c.9199C>T (p.P3067S) alteration is located in exon 25 (coding exon 25) of the PKD1 gene. This alteration results from a C to T substitution at nucleotide position 9199, causing the proline (P) at amino acid position 3067 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |